Basic Information
| LncRNA/CircRNA Name | LINC00152 |
| Synonyms | CYTOR, C2orf59, LINC00152, NCRNA00152 |
| Region | GRCh38_2:87454781-87636740 |
| Ensemble | ENSG00000222041 |
| Refseq | NR_024204 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | colorectal cancer |
| ICD-0-3 | C19.9 |
| Methods | Microarray, qPCR etc. |
| Sample | cell lines (CRC,HCT116,HT29), CRC tissues |
| Expression Pattern | up-regulated |
| Function Description | Residual CRC cell biological characteristics are modulated via LINC00152 silencing.LINC00152,which is known to regulate the cytoskel- eton, may also be involved in cell cycle regulation and DNA damage repair.LINC00152 is a potential oncogene which may be involved in various types of cancer. |
| Pubmed ID | 29541183 |
| Year | 2018 |
| Title | LINC00152 is a potential biomarker involved in the modulation of biological characteristics of residual colorectal cancer cells following chemoradiotherapy. |
External Links
| Links for LINC00152 | GenBank HGNC NONCODE |
| Links for colorectal cancer | OMIM COSMIC |